Latest Regulatory Progress News

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.

Theta Gold Mines has commenced bulk earthworks at its flagship TGME gold project in South Africa and secured nearly US$40 million in combined equity and debt funding, marking a pivotal step toward production.

Kingsrose Mining advances exploration in Norway’s Finnmark region with new geophysical anomalies, while navigating permitting challenges in Finland and focusing on strategic M&A under new leadership.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Kairos Minerals has completed a $27 million placement and secured a landmark mineral rights agreement with Pilbara Minerals, significantly expanding its Mt York Gold Project drilling program and advancing exploration at Roe Hills.

Comet Ridge has made significant progress in its Mahalo Gas Hub development, advancing engineering design and securing independent certification of substantial gas reserves. The company is moving closer to a Final Investment Decision amid ongoing regulatory and commercial negotiations.

Micro-X Ltd has secured its largest-ever $3.3 million Rover Plus order from Malaysia’s Ministry of Health and is progressing critical Head CT imaging trials, supported by a $4.4 million government grant.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.

Jindalee Lithium is progressing its McDermitt Lithium Project with a proposed US SPAC listing, government backing, and an $8 million capital raise, positioning it as a key player in the US critical minerals landscape.

Percheron Therapeutics reports encouraging phase I clinical results for HMBD-002, confirming safety and early efficacy signals, while gearing up for a multi-arm phase II trial in 2026.

Mach7 Technologies reports a pivotal first quarter for FY26, marked by the initial go-live of a major U.S. Veterans Health Administration contract, leadership changes, and a strategic business reset.